COVID-19 Tracker
cases
Vaccine
News
United States
Official resources
Travel Regulations
Total Confirmed Cases
27.1M
+8%
Active cases
145,690
Recovered cases
10,546,905
+13,575
10,546,905
+13,575
Fatal cases
155,195
+77
155,195
+77
Fatality rate
Recovery rate
- Jan 10
- Jan 15
- Jan 20
- Jan 25
- Today
- 320K
- 240K
- 160K
- 80K
- 0
4080
5680
1040
6080
6880
1760
6240
5760
2880
3520
5120
4720
2240
2640
7520
3520
5120
4720
3520
5120
4720
Total Doses Administered
27.1M
+8%
Fully Vaccinated
Recieved atleast one dose
- Jan 10
- Jan 15
- Jan 20
- Jan 25
- Today
- 320K
- 240K
- 160K
- 80K
- 0
4080
5680
1040
6080
6880
1760
6240
5760
2880
3520
5120
4720
2240
2640
7520
3520
5120
4720
3520
5120
4720
4080
5680
1040
6080
6880
1760
6240
5760
2880
3520
5120
4720
2240
2640
7520
PhaseDeveloped by/ResearcherVaccine typeRecruitment status
Phase III/Limited approvalGamaleya Research Institute/Health Ministry RussiaNon-Replicating Viral Vector
Recruiting
See news
Phase III/Limited approvalCanSino Biological Inc./Beijing Institute of BiotechnologyNon-Replicating Viral Vector
Recruiting
See news
Phase III/Limited approvalUniversity of Oxford/AstraZenecaNon-Replicating Viral Vector
Recruiting
See news
Phase IIIResearch Institute for Biological Safety Problems, Rep of KazakhstanInactivated Virus
Enrolling by invitation
See news
Map